Literature DB >> 23389244

Mutational analysis of TSC1 and TSC2 in Japanese patients with tuberous sclerosis complex revealed higher incidence of TSC1 patients than previously reported.

Yo Niida1, Akiko Wakisaka, Takanori Tsuji, Hiroshi Yamada, Mondo Kuroda, Yusuke Mitani, Akiko Okumura, Ayano Yokoi.   

Abstract

Tuberous sclerosis complex (TSC) is an autosomal dominant disorder characterized by multiple hamartias and hamartomas involving throughout the body. To date, many TSC1 and TSC2 mutations have been reported all over the world, however, few TSC mutation studies have been performed in the Japanese population, and genetic characteristics of Japanese TSC patients are not yet clear. In this study, we analyzed TSC1 and TSC2 in 57 Japanese patients with TSC (8 familial and 49 sporadic; 46 definite and 11 suspect TSC) and identified 31 mutations including 11 TSC1 mutations (two familial and nine sporadic; all definite TSC) and 20 TSC2 mutations (2 familial and 18 sporadic; 19 definite and 1 suspect TSC). We also reviewed all Japanese TSC mutations previously reported. Our study demonstrates significantly higher incidence (P=0.007) of TSC1 mutations among sporadic TSC patients in the Japanese population compared with US and European studies. No differences emerged in mutation distributions and types in precedent studies, excepting low frequency of the TSC2 nonsense mutation. Comparing clinical manifestations, developmental delay and/or mental retardation were milder in TSC1 patients than TSC2 patients for its frequency (P=0.032) and severity (P=0.015); however, no other symptoms were clearly different.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23389244     DOI: 10.1038/jhg.2013.3

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  9 in total

1.  Pattern of TSC1 and TSC2 germline mutations in Russian patients with tuberous sclerosis.

Authors:  Evgeny N Suspitsin; Grigoriy A Yanus; Marina Yu Dorofeeva; Tatiana A Ledashcheva; Nataliya V Nikitina; Galina V Buyanova; Elena V Saifullina; Anna P Sokolenko; Evgeny N Imyanitov
Journal:  J Hum Genet       Date:  2018-02-23       Impact factor: 3.172

2.  Establishment of a Regional Interdisciplinary Medical System for Managing Patients with Tuberous Sclerosis Complex (TSC).

Authors:  Ayataka Fujimoto; Tohru Okanishi; Shin Imai; Masaaki Ogai; Akiko Fukunaga; Hidenori Nakamura; Keishiro Sato; Akira Obana; Takayuki Masui; Yoshifumi Arai; Hideo Enoki
Journal:  Sci Rep       Date:  2018-11-13       Impact factor: 4.379

3.  Familial multifocal micronodular pneumocyte hyperplasia with a novel splicing mutation in TSC1: Three cases in one family.

Authors:  Tetsuaki Shoji; Satoshi Konno; Yo Niida; Takahiro Ogi; Masaru Suzuki; Kaoruko Shimizu; Yasuhiro Hida; Kichizo Kaga; Kuniaki Seyama; Tomoaki Naka; Yoshihiro Matsuno; Masaharu Nishimura
Journal:  PLoS One       Date:  2019-02-22       Impact factor: 3.240

Review 4.  Emerging Link between Tsc1 and FNIP Co-Chaperones of Hsp90 and Cancer.

Authors:  Sarah J Backe; Rebecca A Sager; Katherine A Meluni; Mark R Woodford; Dimitra Bourboulia; Mehdi Mollapour
Journal:  Biomolecules       Date:  2022-07-01

Review 5.  Renal phenotypes correlate with genotypes in unrelated individuals with tuberous sclerosis complex in China.

Authors:  Cong Luo; Ye Zhang; Yu-Shi Zhang; Ming-Xin Zhang; Jun Ning; Min-Feng Chen; Yuan Li; Lin Qi; Xiong-Bing Zu; Yang-Le Li; Yi Cai
Journal:  Orphanet J Rare Dis       Date:  2022-07-23       Impact factor: 4.303

6.  Genotype and Phenotype Landscape of 283 Japanese Patients with Tuberous Sclerosis Complex.

Authors:  Sumihito Togi; Hiroki Ura; Hisayo Hatanaka; Yo Niida
Journal:  Int J Mol Sci       Date:  2022-09-22       Impact factor: 6.208

7.  Mutational analysis of TSC1 and TSC2 genes in Tuberous Sclerosis Complex patients from Greece.

Authors:  Socratis Avgeris; Florentia Fostira; Andromachi Vagena; Yiannis Ninios; Angeliki Delimitsou; Radek Vodicka; Radek Vrtel; Sotirios Youroukos; Dimitrios J Stravopodis; Metaxia Vlassi; Aristotelis Astrinidis; Drakoulis Yannoukakos; Gerassimos E Voutsinas
Journal:  Sci Rep       Date:  2017-12-01       Impact factor: 4.379

8.  Mutational analysis of renal angiomyolipoma associated with tuberous sclerosis complex and the outcome of short-term everolimus therapy.

Authors:  Jianxin Ni; Fengqi Yan; Weijun Qin; Lei Yu; Geng Zhang; Fei Liu; Xiaojian Yang; Bo Yang; Chunlin Hao; Teng Wang; Pengfei Liu; Jianlin Yuan; Guojun Wu
Journal:  Sci Rep       Date:  2019-10-04       Impact factor: 4.379

Review 9.  Brain Symptoms of Tuberous Sclerosis Complex: Pathogenesis and Treatment.

Authors:  Masashi Mizuguchi; Maki Ohsawa; Hirofumi Kashii; Atsushi Sato
Journal:  Int J Mol Sci       Date:  2021-06-22       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.